Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Heart Failure × Palliative Care × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 10 Leukemia, Myeloid, Acute 7 Neoplasms 6 Ovarian Neoplasms 4 Lung Neoplasms 4 Pancreatic Neoplasms 3 Glioblastoma 3 Fatigue 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Vulvar Neoplasms 2 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Sarcoma 2 Peritoneal Neoplasms 2 Multiple Myeloma 2 Melanoma 2 Lymphoma 2 Leukemia 2 Hematologic Neoplasms 2 Glioma 2 Genital Neoplasms, Female 2 Esophageal Neoplasms 2 Weight Loss 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Urinary Bladder Neoplasms 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1

Interventions

Electrocardiography 3 Echocardiography 3 Surveys and Questionnaires 2 ziprasidone 1 candesartan 1 Zolpidem 1 Warfarin 1 Vecuronium Bromide 1 Vascular Stiffness 1 Vancomycin 1 Tranexamic Acid 1 Tobramycin 1 Spironolactone 1 Sodium Chloride 1 Simendan 1 Sevelamer 1 Rocuronium 1 Pulse Wave Analysis 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Palliative Care 1 Oxycodone 1 Nutrition Assessment 1 Nifedipine 1 Nafcillin 1 Molindone 1 Metoprolol 1 Methylprednisolone 1 Massage 1 Lysine Acetyltransferase 5 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04598646 2025-12-03

HIMALAYAS-P

University Health Network, Toronto

Phase NA Completed

Behavior, Heart Failure, Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡